IL-6 Promotes compensatory liver regeneration in cirrhotic rat after partial hepatectomy

Cytokine

Volumn 42, Issue 3, 2008, Pages 372-378

  Tiberio, Guido A M ^a   Tiberio, Laura ^b   Benetti, Anna ^b   Cervi, Edoardo ^b   Montani, Nadia ^b   Dreano, Michel ^c   Garotta, Gianni ^c   Cerea, Katia ^b   Steimberg, Nathalie ^b   Pandolfo, GianPietro ^b   Ferrari Bravo, Andrea ^b   Mazzoleni, Giovanna ^b   Giulini, Stefano M ^b   Schiaffonati, Luisa ^b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c Serono International SA   (Switzerland)

Author keywords

Cirrhosis; Hepatocyte proliferation; IL 6 receptors; NF kB; STAT3

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL XL; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN INHIBITOR OF ACTIVATED STAT 3; RECOMBINANT INTERLEUKIN 6; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DOSE RESPONSE; DRUG EFFECT; LIVER CIRRHOSIS; LIVER REGENERATION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT;

ANIMALS; BCL-X PROTEIN; HEPATECTOMY; HEPATOCYTES; HUMANS; I-KAPPA B PROTEINS; INTERLEUKIN-6; LIVER CIRRHOSIS, EXPERIMENTAL; LIVER REGENERATION; MALE; MOLECULAR CHAPERONES; NF-KAPPA B; PROTEIN INHIBITORS OF ACTIVATED STAT; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-6; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

ANIMALIA; RATTUS;

EID: 44549083391     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.03.012     Document Type: Article

References (46)

1. Andiran F., Ayhan A., Tanyel F.C., Abbasoglu O., and Sayek I. Regenerative capacities of normal and cirrhotic livers following 70% hepatectomy in rats and the effect of alpha-tocopherol on cirrhotic regeneration. J Surg Res 89 (2000) 184-188
2. Hashimoto M., and Watanabe G. Functional capacity of the cirrhotic liver after partial hepatectomy in the rat. Surgery 126 (1999) 541-547
3. Blindenbacher A., Wang X., Langer I., Savino R., Terracciano L., and Heim M.H. Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology 38 (2003) 674-682
4. Streetz K.L., Luedde T., Manns M.P., and Trautwein C. Interleukin 6 and liver regeneration. Gut 47 (2000) 309-312
5. Cressman D.E., Greenbaum L.E., DeAngelis R.A., Ciliberto G., Furth E.E., Poli V., et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274 (1996) 1379-1383
6. Tiberio L., Tiberio G.A., Bardella L., Cervi E., Cerea K., Dreano M., et al. Mechanisms of interleukin-6 protection against ischemia-reperfusion injury in rat liver. Cytokine 34 (2006) 131-142
7. Camargo C.A., Madden J.F., Gao W., Selvan R.S., and Clavien P.A. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 26 (1997) 1513-1520
8. Masubuchi Y., Bourdi M., Reilly T.P., Graf M.L., George J.W., and Pohl L.R. Role of interleukin-6 in hepatic heat shock protein expression and protection against acetaminophen-induced liver disease. Biochem Biophys Res Commun 304 (2003) 207-212
9. Jin X., Zhang Z., Beer-Stolz D., Zimmers T.A., and Koniaris L.G. Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection. Hepatology 46 (2007) 802-812
10. Ezure T., Sakamoto T., Tsuji H., Lunz III J.G., Murase N., Fung J.J., et al. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol 156 (2000) 1627-1639
11. Kovalovich K., DeAngelis R.A., Li W., Furth E.E., Ciliberto G., and Taub R. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 31 (2000) 149-159
12. Streetz K.L., Tacke F., Leifeld L., Wustefeld T., Graw A., Klein C., et al. Interleukin 6/gp130-dependent pathways are protective during chronic liver diseases. Hepatology 38 (2003) 218-229
13. Hirano T., Nakajima K., and Hibi M. Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev 8 (1997) 241-252
14. Hirano T., Ishihara K., and Hibi M. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19 (2000) 2548-2556
15. Kovalovich K., Li W., DeAngelis R., Greenbaum L.E., Ciliberto G., and Taub R. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xL. J Biol Chem 276 (2001) 26605-26613
16. Iimuro Y., Nishiura T., Hellerbrand C., Behrns K.E., Schoonhoven R., Grisham J.W., et al. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest 101 (1998) 802-811
17. Plumpe J., Malek N.P., Bock C.T., Rakemann T., Manns M.P., and Trautwein C. NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration. Am J Physiol Gastrointest Liver Physiol 278 (2000) G173-G183
18. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10 (1994) 405-455
19. Tiberio G., Tiberio L., Benetti A., Cervi E., Pandolfo G., Dreano M., et al. Interleukin-6 sustains hepatic regeneration in cirrhotic rat. Hepato-Gastroenterol 54 (2007) 878-883
20. Proctor E., and Chatamra K. High yield micronodular cirrhosis in the rat. Gastroenterology 83 (1982) 1183-1190
21. Portmann BC, MacSween RNM. Pathology of the liver. In: MacSween RNM, Antony PP, Sheuer PJ, Burt AD, Portmann BC, (Eds.), 3rd ed. New York: Churcil Livingstone; 1994. p. 477-512.
22. Kobayashi N., Ito M., Nakamura J., Cai J., Gao C., Hammel J.M., et al. Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology 31 (2000) 851-857
23. Ledda-Columbano G.M., Pibiri M., Loi R., Perra A., Shinozuka H., and Columbano A. Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-bis [2-(3,5-dichloropyridyloxy)] benzene. Am J Pathol 156 (2000) 91-97
24. Peters M., Blinn G., Jostock T., Schirmacher P., Meyer zum Buschenfelde K.H., Galle P.R., et al. Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration. Gastroenterology 119 (2000) 1663-1671
25. Gibson-D'Ambrosio R.E., Crowe D.L., Shuler C.E., and D'Ambrosio S.M. The establishment and continuous subculturing of normal human adult hepatocytes: expression of differentiated liver functions. Cell Biol Toxicol 9 (1993) 385-403
26. Schiaffonati L., Tacchini L., and Pappalardo C. Heat shock response in the liver: expression and regulation of the hsp70 gene family and early response genes after in vivo hyperthermia. Hepatology 20 (1994) 975-983
27. Tunici P., Schiaffonati L., Rabellotti E., Tiberio L., Perin A., and Sessa A. In vivo modulation of 73 kDa heat shock cognate and 78 kDa glucose-regulating protein gene expression in rat liver and brain by ethanol. Alcohol Clin Exp Res 23 (1999) 1861-1867
28. Itoh T., Itoh A., and Pleasure D. Bcl-2-related protein family gene expression during oligodendroglial differentiation. J Neurochem 85 (2003) 1500-1512
29. Muller P.Y., Janovjak H., Miserez A.R., and Dobbie Z. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32 (2002) 1372-1374 1376, 1378-9
30. Chen-Kiang S., Hsu W., Natkunam Y., and Zhang X. Nuclear signaling by interleukin-6. Curr Opin Immunol 5 (1993) 124-128
31. Hong F., Radaeva S., Pan H.N., Tian Z., Veech R., and Gao B. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 40 (2004) 933-941
32. Sun Z., Klein A.S., Radaeva S., Hong F., El-Assal O., Pan H.N., et al. In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. Gastroenterology 125 (2003) 202-215
33. Torbenson M, Yang SQ, Liu HZ, Huang J, Gage W, Diehl AM. STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. Am J Pathol 2002;161:155-61.
34. Li W., Liang X., Kellendonk C., Poli V., and Taub R. STAT3 contributes to the mitogenic response of hepatocytes during liver regeneration. J Biol Chem 277 (2002) 28411-28417
35. Rakemann T., Niehof M., Kubicka S., Fischer M., Manns M.P., Rose-John S., et al. The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro. J Biol Chem 274 (1999) 1257-1266
36. Starkel P., Bishop K., Horsmans Y., and Strain A.J. Expression and DNA-binding activity of signal transducer and activator of transcription 3 in alcoholic cirrhosis compared to normal liver and primary biliary cirrhosis in humans. Am J Pathol 162 (2003) 587-596
37. DeAngelis R.A., Markiewski M.M., Taub R., and Lambris J.D. A high-fat diet impairs liver regeneration in C57BL/6 mice through overexpression of the NF-kappaB inhibitor, IkappaBalpha. Hepatology 42 (2005) 1148-1157
38. Selzner M., and Clavien P.A. Failure of regeneration of the steatotic rat liver: disruption at two different levels in the regeneration pathway. Hepatology 31 (2000) 35-42
39. Yang S.Q., Lin H.Z., Mandal A.K., Huang J., and Diehl A.M. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology 34 (2001) 694-706
40. Streetz K.L., Wustefeld T., Klein C., Kallen K.J., Tronche F., Betz U.A., et al. Lack of gp130 expression in hepatocytes promotes liver injury. Gastroenterology 125 (2003) 532-543
41. Wuestefeld T., Klein C., Streetz K.L., Betz U., Lauber J., Buer J., et al. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 278 (2003) 11281-11288
42. Masson S., Scotte M., Garnier S., Francois A., Hiron M., Teniere P., et al. Differential expression of apoptosis-associated genes post-hepatectomy in cirrhotic vs.normal rats. Apoptosis 5 (2000) 173-179
43. Sosman J.A., Aronson F.R., Sznol M., Atkins M.B., Dutcher J.P., Weiss G.R., et al. Concurrent phase I trials of intravenous interleukin 6 in solid tumor patients: reversible dose-limiting neurological toxicity. Clin Cancer Res 3 (1997) 39-46
44. Veldhuis G.J., Willemse P.H., Sleijfer D.T., van der Graaf W.T., Groen H.J., Limburg P.C., et al. Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer. J Clin Oncol 13 (1995) 2585-2593
45. Makuuchi M., Thai B.L., Takayasu K., Takayama T., Kosuge T., Gunven P., et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107 (1990) 521-527
46. Jaeck D., Bachellier P., Nakano H., Oussoultzoglou E., Weber J.C., Wolf P., et al. One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg 185 (2003) 221-229